NGeneBio Co., Ltd.
Medical Devices - Seoul, Seoul, South Korea
NGeneBio Co., Ltd. Employees
NGeneBio Co., Ltd. Senior Management
NGeneBio Co., Ltd. Details
NGeneBio Co., Ltd. is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was founded in October 2015, headquartered in Seoul, South Korea as a joint venture between Genecurix and Korea Telecom. The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTestTM) with clinical analysis SW (NGeneAnalysisTM) in 2016. BRCA NGS panel for PARP inhibitor CDx test and solid tumor/hematologic cancer NGS panels will be launched, inclusive of clinical data analysis SW platform. The mission of the company is to provide clinically validated NGS based IVD/CDx products/services with convergence of innovative bioinformatics and SW development capacity for global market. For more information, visit www.ngenebio.com.
NGeneBio Co., Ltd. Technologies
Load Balancers
Ubuntu
CMS
WordPress.org
Tag Management
Google Tag Manager
Fonts
Google Font API
Analytics and Tracking
Google Analytics
Other
Mobile Friendly